Prolonged myocardial stunning after thrombolysis: can left ventricular function be assessed definitely at hospital

M Pfisterer1, M Zuber, R Wenzel

  • 1Division of Cardiology, University Hospital, Basel, Switzerland.

European Heart Journal
|February 1, 1991
PubMed

Insights

Myocardial stunning, or dysfunction after reperfusion, can show delayed recovery. Left ventricular ejection fraction may improve significantly over several months, especially with early reperfusion.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Acute myocardial infarction requires timely reperfusion to restore blood flow.
  • Myocardial stunning is a transient dysfunction following reperfusion.
  • The potential for delayed recovery of left ventricular function after reperfusion is not fully understood.

Purpose of the Study:

  • To assess the delayed recovery of myocardial function after acute reperfusion.
  • To determine if left ventricular ejection fraction (LVEF) improves beyond the acute phase.
  • To identify factors influencing delayed functional recovery.

Main Methods:

  • Utilized radionuclide angiocardiography to assess LVEF in 33 patients from the European Cooperative Study (rtPA vs placebo).
  • Evaluated LVEF on day 9 and again at 3-6 months post-reperfusion.
  • Correlated LVEF changes with early reperfusion markers (peak creatine kinase time) and infarct-related artery patency.

Main Results:

  • Seventeen patients with depressed LVEF on day 9 showed significant improvement by 3-6 months (38.8% to 45.2%, P < 0.01).
  • Delayed recovery was observed primarily in patients with early reperfusion (peak CK ≤ 15h) and open infarct-related arteries.
  • Patients without early reperfusion or with persistent arterial occlusion did not show significant LVEF improvement.

Conclusions:

  • Depressed left ventricular ejection fraction after reperfusion may exhibit delayed recovery due to prolonged myocardial stunning.
  • Left ventricular function assessment immediately after hospital discharge may not be definitive.
  • Thrombolysis outcomes require cautious interpretation, considering the potential for delayed functional improvement.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...